{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:03:36Z","timestamp":1768003416019,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T00:00:00Z","timestamp":1391990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-74","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T15:01:30Z","timestamp":1392044490000},"source":"Crossref","is-referenced-by-count":46,"title":["Community-based HCV screening: knowledge and attitudes in a high risk urban population"],"prefix":"10.1186","volume":"14","author":[{"given":"Brianna L","family":"Norton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrine I","family":"Voils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H","family":"Timberlake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J","family":"Hecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neela D","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim M","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneka","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Naggie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason E","family":"Stout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,10]]},"reference":[{"issue":"10","key":"3067_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ: The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006, 144 (10): 705-714. 10.7326\/0003-4819-144-10-200605160-00004.","journal-title":"Ann Intern Med"},{"key":"3067_CR2","volume-title":"Combating the Silent Epidemic of Viral Hepatitis (Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis)","author":"US Department of Health and Human Services","year":"2011","unstructured":"US Department of Health and Human Services: Combating the Silent Epidemic of Viral Hepatitis (Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis). 2011"},{"issue":"4","key":"3067_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.cld.2006.08.012","volume":"10","author":"EC Verna","year":"2006","unstructured":"Verna EC, Brown RS: Hepatitis C virus and liver transplantation. Clin Liver Dis. 2006, 10 (4): 919-940. 10.1016\/j.cld.2006.08.012.","journal-title":"Clin Liver Dis"},{"issue":"3","key":"3067_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.23561","volume":"51","author":"AE Mitchell","year":"2010","unstructured":"Mitchell AE, Colvin HM, Palmer Beasley R: Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010, 51 (3): 729-733. 10.1002\/hep.23561.","journal-title":"Hepatology"},{"issue":"6","key":"3067_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/003335490612100611","volume":"121","author":"H Hagan","year":"2006","unstructured":"Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, Hudson S, Garfein RS: Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Rep. 2006, 121 (6): 710-719.","journal-title":"Public Health Rep"},{"issue":"4","key":"3067_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","volume":"156","author":"KN Ly","year":"2012","unstructured":"Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD: The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012, 156 (4): 271-278. 10.7326\/0003-4819-156-4-201202210-00004.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3067_CR7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","volume":"138","author":"GL Davis","year":"2010","unstructured":"Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW: Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010, 138 (2): 513-521. 10.1053\/j.gastro.2009.09.067. 521 e511-516","journal-title":"Gastroenterology"},{"issue":"1","key":"3067_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.dld.2010.05.006","volume":"43","author":"DB Rein","year":"2011","unstructured":"Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB: Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis. 2011, 43 (1): 66-72. 10.1016\/j.dld.2010.05.006.","journal-title":"Dig Liver Dis"},{"issue":"RR-19","key":"3067_CR9","first-page":"1","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention: Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998, 47 (RR-19): 1-39.","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"3067_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7326\/0003-4819-157-9-201211060-00529","volume":"157","author":"BD Smith","year":"2012","unstructured":"Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Ward JW: Hepatitis C virus testing of persons born during 1945\u20131965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med. 2012, 157 (11): 817-822. 10.7326\/0003-4819-157-9-201211060-00529.","journal-title":"Ann Intern Med"},{"key":"3067_CR11","volume-title":"Ann Intern Med","author":"VA Moyer","year":"2013","unstructured":"Moyer VA: Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2013"},{"key":"3067_CR12","volume-title":"A Novel Method of Reaching at-Risk Populations in Community Outreach Hepatitis Screening Programs","author":"GW Guerrero HJ","year":"2008","unstructured":"Guerrero HJ GW, Fullmer C: A Novel Method of Reaching at-Risk Populations in Community Outreach Hepatitis Screening Programs. 2008, San Fransisco, CA: AASLD"},{"issue":"Suppl 2","key":"3067_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/00333549071220S203","volume":"122","author":"J Subiadur","year":"2007","unstructured":"Subiadur J, Harris JL, Rietmeijer CA: Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado. Public Health Rep. 2007, 122 (Suppl 2): 12-17.","journal-title":"Public Health Rep"},{"issue":"3","key":"3067_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/00007435-200103000-00008","volume":"28","author":"RA Gunn","year":"2001","unstructured":"Gunn RA, Murray PJ, Ackers ML, Hardison WG, Margolis HS: Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis. 2001, 28 (3): 166-170. 10.1097\/00007435-200103000-00008.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"3067_CR15","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/j.1475-6773.2004.00302.x","volume":"39","author":"J Hadley","year":"2004","unstructured":"Hadley J, Cunningham P: Availability of safety net providers and access to care of uninsured persons. Health Serv Res. 2004, 39 (5): 1527-1546. 10.1111\/j.1475-6773.2004.00302.x.","journal-title":"Health Serv Res"},{"issue":"4","key":"3067_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/00007435-200304000-00013","volume":"30","author":"RA Gunn","year":"2003","unstructured":"Gunn RA, Murray PJ, Brennan CH, Callahan DB, Alter MJ, Margolis HS: Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project. Sex Transm Dis. 2003, 30 (4): 340-344. 10.1097\/00007435-200304000-00013.","journal-title":"Sex Transm Dis"},{"issue":"7","key":"3067_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1046\/j.1360-0443.2001.967100710.x","volume":"96","author":"M McCusker","year":"2001","unstructured":"McCusker M: Influence of hepatitis C status on alcohol consumption in opiate users in treatment. Addiction. 2001, 96 (7): 1007-1014. 10.1046\/j.1360-0443.2001.967100710.x.","journal-title":"Addiction"},{"issue":"2","key":"3067_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0033-3182(10)70675-7","volume":"51","author":"E Dieperink","year":"2010","unstructured":"Dieperink E, Ho SB, Heit S, Durfee JM, Thuras P, Willenbring ML: Significant reductions in drinking following brief alcohol treatment provided in a hepatitis C clinic. Psychosomatics. 2010, 51 (2): 149-156. 10.1016\/S0033-3182(10)70675-7.","journal-title":"Psychosomatics"},{"issue":"4","key":"3067_CR19","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009, 49 (4): 1335-1374. 10.1002\/hep.22759.","journal-title":"Hepatology"},{"issue":"5","key":"3067_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-140-5-200403020-00033","volume":"140","author":"S Zeuzem","year":"2004","unstructured":"Zeuzem S: Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?. Ann Intern Med. 2004, 140 (5): 370-381.","journal-title":"Ann Intern Med"},{"issue":"3 Suppl 1","key":"3067_CR21","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.1002\/hep.510260721","volume":"26","author":"GL Davis","year":"1997","unstructured":"Davis GL, Lau JY: Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology. 1997, 26 (3 Suppl 1): 122S-127S.","journal-title":"Hepatology"},{"issue":"4","key":"3067_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jhep.2010.04.024","volume":"53","author":"WS Cheng","year":"2010","unstructured":"Cheng WS, Roberts SK, McCaughan G, Sievert W, Weltman M, Crawford D, Rawlinson W, Marks PS, Thommes J, Rizkalla B, et al: Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing. J Hepatol. 2010, 53 (4): 616-623. 10.1016\/j.jhep.2010.04.024.","journal-title":"J Hepatol"},{"issue":"20","key":"3067_CR23","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1056\/NEJMoa1214854","volume":"368","author":"IM Jacobson","year":"2013","unstructured":"Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS, Shiffman ML, Lawitz E, Everson G, Bennett M, et al: Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med. 2013, 368 (20): 1867-1877. 10.1056\/NEJMoa1214854.","journal-title":"N Engl J Med"},{"issue":"20","key":"3067_CR24","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","volume":"368","author":"E Lawitz","year":"2013","unstructured":"Lawitz E, Mangia A, Wyles D, Rodriguez-Torres M, Hassanein T, Gordon SC, Schultz M, Davis MN, Kayali Z, Reddy KR, et al: Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med. 2013, 368 (20): 1878-1887. 10.1056\/NEJMoa1214853.","journal-title":"N Engl J Med"},{"issue":"1","key":"3067_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11894-012-0303-3","volume":"15","author":"D Hunt","year":"2013","unstructured":"Hunt D, Pockros P: What are the promising new therapies in the field of chronic hepatitis C after the first-generation direct-acting antivirals?. Curr Gastroenterol Rep. 2013, 15 (1): 303-","journal-title":"Curr Gastroenterol Rep"},{"issue":"Suppl 5","key":"3067_CR26","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1086\/427450","volume":"40","author":"AH Litwin","year":"2005","unstructured":"Litwin AH, Soloway I, Gourevitch MN: Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities. Clin Infect Dis. 2005, 40 (Suppl 5): S339-345.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3067_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.dld.2011.12.014","volume":"44","author":"AH Litwin","year":"2012","unstructured":"Litwin AH, Smith BD, Drainoni ML, McKee D, Gifford AL, Koppelman E, Christiansen CL, Weinbaum CM, Southern WN: Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk. Dig Liver Dis. 2012, 44 (6): 497-503. 10.1016\/j.dld.2011.12.014.","journal-title":"Dig Liver Dis"},{"issue":"11","key":"3067_CR28","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.2105\/AJPH.2012.300659","volume":"102","author":"ML Drainoni","year":"2012","unstructured":"Drainoni ML, Litwin AH, Smith BD, Koppelman EA, McKee MD, Christiansen CL, Gifford AL, Weinbaum CM, Southern WN: Effectiveness of a risk screener in identifying hepatitis C virus in a primary care setting. Am J Public Health. 2012, 102 (11): e115-121. 10.2105\/AJPH.2012.300659.","journal-title":"Am J Public Health"},{"issue":"1","key":"3067_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsat.2008.09.009","volume":"37","author":"AH Litwin","year":"2009","unstructured":"Litwin AH, Harris KA, Nahvi S, Zamor PJ, Soloway IJ, Tenore PL, Kaswan D, Gourevitch MN, Arnsten JH: Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program. J Subst Abuse Treat. 2009, 37 (1): 32-40.","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"3067_CR30","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s10461-010-9870-1","volume":"15","author":"RJ Proeschold-Bell","year":"2011","unstructured":"Proeschold-Bell RJ, Hoeppner B, Taylor B, Cohen S, Blouin R, Stringfield B, Muir AJ: An interrupted time series evaluation of a hepatitis C intervention for persons with HIV. AIDS Behav. 2011, 15 (8): 1721-1731. 10.1007\/s10461-010-9870-1.","journal-title":"AIDS Behav"},{"issue":"12","key":"3067_CR31","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.addbeh.2008.07.005","volume":"33","author":"S O\u2019Brien","year":"2008","unstructured":"O\u2019Brien S, Day C, Black E, Dolan K: Injecting drug users\u2019 understanding of hepatitis C. Addict Behav. 2008, 33 (12): 1602-1605. 10.1016\/j.addbeh.2008.07.005.","journal-title":"Addict Behav"},{"issue":"7","key":"3067_CR32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/SMJ.0b013e3181e1dde1","volume":"103","author":"RJ Proeschold-Bell","year":"2010","unstructured":"Proeschold-Bell RJ, Blouin R, Reif S, Amana A, Rowland BJ, Lombard F, Stringfield B, Muir AJ: Hepatitis C transmission, prevention, and treatment knowledge among patients with HIV. South Med J. 2010, 103 (7): 635-641. 10.1097\/SMJ.0b013e3181e1dde1.","journal-title":"South Med J"},{"issue":"11","key":"3067_CR33","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1365-2893.2010.01383.x","volume":"18","author":"K Krauskopf","year":"2011","unstructured":"Krauskopf K, McGinn TG, Federman AD, Halm EA, Leventhal H, McGinn LK, Gardenier D, Oster A, Kronish IM: HIV and HCV health beliefs in an inner-city community. J Viral Hepat. 2011, 18 (11): 785-791. 10.1111\/j.1365-2893.2010.01383.x.","journal-title":"J Viral Hepat"},{"issue":"7","key":"3067_CR34","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","volume":"31","author":"C Treloar","year":"2012","unstructured":"Treloar C, Hull P, Dore GJ, Grebely J: Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs. Drug Alcohol Rev. 2012, 31 (7): 918-924. 10.1111\/j.1465-3362.2012.00468.x.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"3067_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","volume":"33","author":"SH Mehta","year":"2008","unstructured":"Mehta SH, Genberg BL, Astemborski J, Kavasery R, Kirk GD, Vlahov D, Strathdee SA, Thomas DL: Limited uptake of hepatitis C treatment among injection drug users. J Community Health. 2008, 33 (3): 126-133. 10.1007\/s10900-007-9083-3.","journal-title":"J Community Health"},{"issue":"1","key":"3067_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10620-010-1455-3","volume":"56","author":"M Surjadi","year":"2011","unstructured":"Surjadi M, Torruellas C, Ayala C, Yee HF, Khalili M: Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Dig Dis Sci. 2011, 56 (1): 213-219. 10.1007\/s10620-010-1455-3.","journal-title":"Dig Dis Sci"},{"issue":"Suppl 5","key":"3067_CR37","doi-asserted-by":"publisher","first-page":"S313","DOI":"10.1086\/427446","volume":"40","author":"A Doab","year":"2005","unstructured":"Doab A, Treloar C, Dore GJ: Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis. 2005, 40 (Suppl 5): S313-320.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3067_CR38","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/liv.12150","volume":"33","author":"S Lubega","year":"2013","unstructured":"Lubega S, Agbim U, Surjadi M, Mahoney M, Khalili M: Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver Int. 2013, 33 (7): 999-1007. 10.1111\/liv.12150.","journal-title":"Liver Int"},{"key":"3067_CR39","first-page":"CD006424","volume":"3","author":"K Hawthorne","year":"2008","unstructured":"Hawthorne K, Robles Y, Cannings-John R, Edwards AG: Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups. Cochrane Database Syst Rev. 2008, 3: CD006424-","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3067_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jadohealth.2005.12.029","volume":"39","author":"SM Kiene","year":"2006","unstructured":"Kiene SM, Barta WD: A brief individualized computer-delivered sexual risk reduction intervention increases HIV\/AIDS preventive behavior. J Adolesc Health. 2006, 39 (3): 404-410. 10.1016\/j.jadohealth.2005.12.029.","journal-title":"J Adolesc Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-74\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T05:02:03Z","timestamp":1548219723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3067"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-74","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,10]]},"article-number":"74"}}